Inventor
KRAMER JAMES B
US15 patents
⚠️ This page may combine multiple inventors who share the name “KRAMER JAMES B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
WARNER LAMBERT CO
10 patentsUS4981865AJan 1, 1991
N-hydroxyamide, N-hydroxythioamide, hydroxyurea, and N-hydroxythiourea derivatives of selected nsaids as antiinflammatory agents
WARNER LAMBERT CO57 citations96
US5350748ASep 27, 1994
3-thio or amino substituted-benzo[b]thiophene-2-carboxamides and 3-oxygen, thio, or amino substituted-benzofuran-2-carboxamides as inhibitors of cell adhesion
WARNER LAMBERT CO44 citations92
US5112846AMay 12, 1992
N-hydroxyamide, N-hydroxythioamide, hydroxyurea, and N-hydroxythiourea derivatives of selected nsaids as antiinflammatory agents
WARNER LAMBERT CO28 citations92
US5434188AJul 18, 1995
1-ether and 1-thioether-naphthalene-2-carboxamides as inhibitors of cell adhesion and as inhibitors of the activation of HIV
WARNER LAMBERT CO48 citations90
US5571825ANov 5, 1996
Method of selectively inhibiting prostaglandin G/H synthase-2
WARNER LAMBERT CO30 citations89
US5075330ADec 24, 1991
N-hydroxyamide, N-hydroxythioamide, N-hydroxyurea, and N-hydroxythiourea derivatives of selected NSAIDS as antiinflammatory agents
WARNER LAMBERT CO21 citations82
US5565446AOct 15, 1996
Benzothiophene, benzofuran and indole-thiazepinones, oxazepinones and diazepinones as inhibitors of cell adhesion and as inhibitors of HIV
WARNER LAMBERT CO11 citations74
US5102897AApr 7, 1992
3,5-ditertiarybutyl-4-hydroxyphenyl, 1,3,4-thiadiazoles and oxadiazoles linked by carbon, oxygen, and sulfur residues
WARNER LAMBERT CO12 citations74
US5489586AFeb 6, 1996
Method for treating inflammatory disease in humans
WARNER LAMBERT CO4 citations63
US5442111AAug 15, 1995
3,5-di-tetriary-4-butyl-4-hydroxyphenyloxy- or tioalkylene N-hydroxyamides, N-hydroxythioamides, N-hydroxyureas, and N-hydroxythioureas as 5-lipoxygenase inhibitors
WARNER LAMBERT CO2 citations62